Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Rostelecom to spend up to ₽15 billion on M&A deals

11/15/23 RTKM

UTair suspends operation of 30 Mi-17 helicopters

11/15/23 UTAR

Whoosh launches long-term employee incentive program

11/15/23 WUSH

Samolot expands its presence in the business class segment

11/15/23 SMLT

Magnit reported for 9 months of 2023 by IFRS

11/15/23 MGNT

Nike announced a quarterly dividend

11/15/23 NKE

Magnit's retail revenue for 9 months increased by 7.7%

11/15/23 MGNT

Board of Directors of Rosneft Oil Company recommended that dividends be paid for 9 months 2023

11/15/23 ROSN

Bloomberg has learned details of Yandex's new restructuring plan

11/14/23 YNDX

US sanctions will not affect Segezha Group's operations

11/14/23 SGZH